Welcome to visit Zhongnan Medical Journal Press Series journal website!

Advancement in biomarker of neonatal sepsis

Published on Dec. 18, 2024Total Views: 37 timesTotal Downloads: 16 timesDownloadMobile

Author: QIANG Yuehua YANG Guang GAO Jingying

Affiliation: Department of Pediatrics, Shanxi Medical University, Taiyuan 030001, China

Keywords: Neonatal sepsis Biomarker Early diagnosis Prognosis

DOI: 10.12173/j.issn.1004-5511.202407021

Reference: Qiang YH, Yang G, Gao JY, et al. Advancement in biomarker of neonatal sepsis[J]. Yixue Xinzhi Zazhi, 2024, 34(11): 1302-1310. DOI: 10.12173/j.issn.1004-5511.202407021. [Article in Chinese]

  • Abstract
  • Full-text
  • References
Abstract

Neonatal sepsis (NS) is one of the critical diseases in the neonatal period, with a high incidence rate and mortality. Blood culture serves as the gold standard for diagnosing NS, but it takes a long time and has a low positive rate. Therefore, finding more efficient biomarker for early diagnosis and guiding antibiotic treatment is extremely important for improving the prognosis of NS. This article reviews the current research status of biomarker related to routine laboratory indicators, cytokines, cell surface antigens, and metagenomic sequencing, to provide assistance for the early diagnosis of NS.

Full-text
Please download the PDF version to read the full text: download
References

1.中华医学会儿科学分会新生儿学组, 中华儿科杂志编辑委员会. 新生儿败血症诊断与治疗专家共识(2024)[J]. 中华儿科杂志, 2024, 62(10): 931-940. [The Neonatology Group of the Chinese Medical Association Science Branch, Editorial Committee of the Chinese Journal of Pediatrics. Expert consensus on diagnosis and management of neonatal bacteria sepsis (2024)[J]. Chinese Journal of Pediatrics, 2024, 62(10): 931-940.] DOI: 10.3760/cma.j.cn112140-20240505-00307.

2.Fleischmann-Struzek C, Goldfarb DM, Schlattmann P, et  al. The global burden of paediatric and neonatal sepsis: a systematic review[J]. Lancet Respir Med, 2018, 6(3): 223-230. DOI: 10.1016/s2213-2600(18)30063-8.

3.Shil PK, Majumder BK, Basak AK, et al. Role of white blood cell count, immature to total ratio and C-reactive protein in early detection of clinically suspected neonatal sepsis[J]. Mymensingh Med J, 2023, 32(3): 721-726. https://pubmed.ncbi.nlm.nih.gov/37391965/.

4.Martin SL, Desai S, Nanavati R, et al. Red cell distribution width and its association with mortality in neonatal sepsis[J]. J Matern Fetal Neonatal Med, 2019, 32(12): 1925-1930. DOI: 10.1080/14767058.2017.1421932.

5.Gatseva P, Blazhev A, Yordanov Z, et al. Early diagnostic markers of late-onset neonatal sepsis[J]. Pediatr Rep, 2023, 15(3): 548-559. DOI: 10.3390/pediatric15030050.

6.汪丹丹, 李亚林, 万元. 新生儿败血症NEU%、PCT、PLT的表达水平及临床指导意义[J]. 分子诊断与治疗杂志, 2023, 15(8): 1327-1330. [Wang DD, Li YL, Wan Y, et al. Expression levels and clinical significance of NEU%, PCT, PLT in neonatal sepsis[J]. Journal of Molecular Diagnostics and Therapy, 2023, 15(8): 1327-1330.] DOI: 10.3969/j.issn.1674-6929.2023.08.012.

7.Shaaban HA, Safwat N. Mean platelet volume in preterm: a predictor of early onset neonatal sepsis[J]. J Matern Fetal Neonatal Med, 2020, 33(2): 206-211. DOI: 10.1080/ 14767058.2018.1488161.

8.Mishra S, Jaiswar S, Saad S, et al. Platelet indices as a predictive marker in neonatal sepsis and respiratory distress in preterm prelabor rupture of membranes[J]. Int J Hematol, 2021, 113(2): 199-206. DOI: 10.1007/s12185-020-03025-2.

9.Gopal N, Chauhan N, Jain U, et al. Advancement in biomarker based effective diagnosis of neonatal sepsis[J]. Artif Cells Nanomed Biotechnol, 2023, 51(1): 476-490. DOI: 10.1080/21691401.2023.2252016.

10.Sharma D, Farahbakhsh N, Shastri S, et al. Biomarkers for diagnosis of neonatal sepsis: a literature review[J]. J Matern Fetal Neonatal Med, 2018, 31(12): 1646-1659. DOI: 10.1080/14767058.2017.1322060.

11.Ramavath C, Katam SK, Vardhelli V, et al. Examining the utility of rapid salivary C-reactive protein as a predictor for neonatal sepsis: an analytical cross-sectional pilot study[J]. Diagnostics (Basel), 2023, 13(5): 867. DOI: 10.3390/diagnostics13050867.

12.Memar MY, Alizadeh N, Varshochi M, et al. Immunologic biomarkers for diagnostic of early-onset neonatal sepsis[J]. J Matern Fetal Neonatal Med, 2019, 32(1): 143-153. DOI: 10.1080/14767058.2017.1366984.

13.Stocker M, van Herk W, El Helou S, et al. Procalcitonin-guided decision making for duration of antibiotic therapy in neonates with suspected early-onset sepsis: a multicentre, randomised controlled trial (neopins)[J]. Lancet, 2017, 390(10097): 871-881. DOI: 10.1016/s0140-6736(17) 31444-7.

14.Rees CA, Lim J, Westbrook AL, et al. Systematic review and Meta-analysis of the diagnostic value of four biomarkers in detecting neonatal sepsis in low-and middle-income countries[J]. BMJ Paediatr Open, 2023, 7(1): e001627. DOI: 10.1136/bmjpo-2022-001627.

15.Patel K, McElvania E. Diagnostic challenges and laboratory considerations for pediatric sepsis[J]. J Appl Lab Med, 2019, 3(4): 587-600. DOI: 10.1373/jalm.2017.025908.

16.Bourika V, Hantzi E, Michos A, et al. Clinical value of serum amyloid-a protein, high-density lipoprotein cholesterol and apolipoprotein-A1 in the diagnosis and follow-up of neonatal sepsis[J]. Pediatr Infect Dis J, 2020, 39(8): 749-755. DOI: 10.1097/inf.0000000000002682.

17.Oshima Y, Tanaka S, Tsumura K, et al. Amniotic fluid gram stain and interleukin-6 can predict early-onset neonatal sepsis[J]. J Obstet Gynaecol Res, 2020. DOI: 10.1111/jog.14595.

18.Ebenebe CU, Hesse F, Blohm ME, et al. Diagnostic accuracy of interleukin-6 for early-onset sepsis in preterm neonates[J]. J Matern Fetal Neonatal Med, 2021, 34(2): 253-258. DOI: 10.1080/14767058.2019.1606194.

19.周炜, 俞君, 曾雪琪, 等. 白介素-6和降钙素原在低出生体重新生儿细菌感染性疾病中的预测价值 [J]. 中国医药导报, 2020, 17(21): 109-112. [Zhou  W, Yu J, Zeng XQ, et al. The value of interleukin-6 and procalcitonin to predict bacterial infection in low birth weight neonates[J]. China Medical Herald, 2020, 17(21): 109-112.] https://xueshu.baidu.com/usercenter/paper/show?paperid=102g08x0p71t04m0t70x0e10dt279040&site=xueshu_se&hitarticle=1

20.Xing W, Wang Y, Liu J, et al. Role of interleukins in the detection of neonatal sepsis: a network Meta-analysis[J]. Front Pediatr, 2023, 11: 1267777. DOI: 10.3389/fped. 2023.1267777.

21.柳丽丽, 金尾静, 周素芽. 肿瘤坏死因子α诊断新生儿败血症的Meta分析[J]. 中国妇幼保健, 2020, 35(7): 1361-1366. [Liu LL, Jin WJ, Zhou SY. Diagnostic value of tumor necrosis factor-α for neonatal sepsis: a Meta-analysis[J]. Maternal & Child Health Care of China, 2020, 35(7): 1361-1366.] DOI: 10.19829/j.zgfybj.issn.1001-4411.2020.07.060.

22.杨晓燕, 石晶, 赵静, 等. 中性粒细胞CD64诊断新生儿败血症准确性的Meta分析[J]. 中国新生儿科杂志, 2016, 31(3): 201-205. [Yang XY, Shi J, Zhao J, et al. Diagnostic value of neutrophil CD64 for neonatal sepsis: a Meta-analysis[J]. Chinese Journal of Neonatology, 2016, 31(3): 201-205.] DOI: 10.3969/j.issn.1673-6710.2016. 03.010.

23.Hashem HE, Abdel Halim RM, El Masry SA, et al. The utility of neutrophil CD64 and presepsin as diagnostic, prognostic, and monitoring biomarkers in neonatal sepsis[J]. Int J Microbiol, 2020, 2020: 8814892. DOI: 10.1155/2020/8814892.

24.Soucek O, Kacerovsky M, Musilova I, et al. Amniotic fluid CD11b levels in pregnancies complicated by preterm prelabor rupture of membranes[J]. J Matern Fetal Neonatal Med, 2022, 35(9): 1703-1711. DOI: 10.1080/14767058. 2020.1767578.

25.ELMeneza S, Mohamed W, Elbagoury I, et al. Role of neutrophil CD11b expression in diagnosis of earlyonset neonatal sepsis in full-term infant[J]. Clin Exp Pediatr, 2021, 64(1): 44-45. DOI: 10.3345/cep.2019.01319.

26.Bellos I, Fitrou G, Daskalakis G, et al. Soluble TREM-1 as a predictive factor of neonatal sepsis: a Meta-analysis[J]. Inflamm Res, 2018, 67(7): 571-578. DOI: 10.1007/s00011-018-1149-4.

27.Chang C, Gao Q, Deng G, et al. Diagnostic and prognostic predictive values of triggering receptor expressed on myeloid cell-1 expression in neonatal sepsis: a Meta-analysis and systematic review[J]. Front Pediatr, 2022, 10: 929665. DOI: 10.3389/fped.2022.929665.

28.Poggi C, Lucenteforte E, Petri D, et al. Presepsin for the diagnosis of neonatal early-onset sepsis: a systematic review and Meta-analysis[J]. JAMA Pediatr, 2022, 176(8): 750-758. DOI: 10.1001/jamapediatrics.2022.1647.

29.van Maldeghem I, Nusman CM, Visser DH. Soluble CD14 subtype (SCD14-ST) as biomarker in neonatal early-onset sepsis and late-onset sepsis: a systematic review and Meta-analysis[J]. BMC Immunol, 2019, 20(1): 17. DOI: 10.1186/s12865-019-0298-8.

30.万君, 卢晓颖, 张晓梅. 血浆可溶性CD14亚型在新生儿败血症中的研究进展[J]. 国际儿科学杂志, 2022, 49(8): 553-557. [Wan J, Lu XY, Zhang XM. Progress of plasma soluble CD14 subtype in neonatal septicemia[J]. International Journal of Pediatrics, 2022, 49(8): 553-557.] DOI: 10.3760/cma.j.issn.1673-4408.2022.08.011.

31.赵艳梅, 曹孟宸, 王颍源, 等. 血清ADMA、IL-6、内毒素及乳酸在新生儿败血症所致感染性休克中的表达及临床意义[J]. 临床医学研究与实践, 2024, 9(9): 93-96. [Zhao YM, Cao MC, Wang YY, et al. Expression and clinical significance of serum ADMA, IL-6, endotoxin and lactic acid in septic shock caused by neonatal sepsis[J]. Clinical Research and Practice, 2024, 9(9): 93-96.] DOI: 10.19347/j.cnki.2096-1413.202409023.

32.Yilmaz A, Kaya N, Gonen I, et al. Evaluating of neonatal early onset sepsis through lactate and base excess monitoring[J]. Sci Rep, 2023, 13(1): 14837. DOI: 10.1038/s41598-023-41776-0.

33.Roth DE, Morris SK, Zlotkin S, et al. Vitamin D supplementation in pregnancy and lactation and infant growth[J]. N Engl J Med, 2018, 379(6): 535-546. DOI: 10.1056/NEJMoa1800927.

34.Gamal TS, Madiha AS, Hanan MK, et al. Neonatal and maternal 25-oh vitamin D serum levels in neonates with early-onset sepsis[J]. Children (Basel), 2017, 4(5): 37. DOI: 10.3390/children4050037.

35.Ma J, Chen X, Wang X, et al. The accuracy of soluble urokinase-type plasminogen activator receptor for the diagnosis of neonatal sepsis: a Meta-analysis[J]. Front Med (Lausanne), 2023, 10: 1169114. DOI: 10.3389/fmed.2023. 1169114.

36.赵双葵, 许燕萍. 新生儿败血症早期诊断生物标志物的研究进展[J]. 国际儿科学杂志, 2024, 51(5): 331-334. [Zhao SK, Xu YP. Advances in biomarkers for early diagnosis of neonatal sepsis[J]. International Journal of Pediatrics, 2024, 51(5): 331-334.] DOI: 10.3760/cma.j.issn.1673-4408.2024.05.010.

37.Gu W, Deng X, Lee M, et al. Rapid pathogen detection by metagenomic next-generation sequencing of infected body fluids[J]. Nat Med, 2021, 27(1): 115-124. DOI: 10.1038/s41591-020-1105-z.

38.Agudelo-Pérez S, Fernández-Sarmiento J, Rivera León  D, et al. Metagenomics by next-generation sequencing (mNGS) in the etiological characterization of neonatal and pediatric sepsis: a systematic review[J]. Front Pediatr, 2023, 11: 1011723. DOI: 10.3389/fped.2023.1011723.

39.《中华传染病杂志》编辑委员会. 中国宏基因组学第二代测序技术检测感染病原体的临床应用专家共识[J]. 中华传染病杂志, 2020, 38(11): 681-689. [Editorial Board of Chinese Journal of Infectious Diseases. Clinical practice expert consensus for the application of metagenomic next generation sequencing[J]. Chinese Journal of Infectious Diseases, 2020, 38(11): 681-689.] DOI: 10.3760/cma.j.cn311365-20200731-00732.

40.Boscarino G, Migliorino R, Carbone G, et al. Biomarkers of neonatal sepsis: where we are and where we are going[J]. Antibiotics (Basel), 2023, 12(8): 1233. DOI: 10.3390/antibiotics12081233.

41.Formosa A, Turgeon P, Dos Santos CC. Role of miRNA dysregulation in sepsis[J]. Mol Med, 2022, 28(1): 99. DOI: 10.1186/s10020-022-00527-z.

42.Sullivan BA, Kausch SL, Fairchild KD. Artificial and human intelligence for early identification of neonatal sepsis[J]. Pediatr Res, 2023, 93(2): 350-356. DOI: 10.1038/s41390-022-02274-7.

43.Koppens HJ, Onland W, Visser DH, et al. Heart rate characteristics monitoring for late-onset sepsis in preterm infants: a systematic review[J]. Neonatology, 2023, 120(5): 548-557. DOI: 10.1159/000531118.

44.O'Sullivan C, Tsai DH, Wu IC, et al. Machine learning applications on neonatal sepsis treatment: a scoping review[J]. BMC Infect Dis, 2023, 23(1): 441. DOI: 10.1186/s12879-023-08409-3.

45.束礼梅, 李秋芳, 顾慧敏, 等. 机器学习在新生儿败血症早期识别和护理中的研究进展[J]. 中华急危重症护理杂志, 2023, 4(6): 515-518. [Shu LM, Li QF, Gu HM, et al. Research progress of machine learning in the early identification and nursing of neonatal sepsis[J]. Chinese Journal of Emergency and Critical Care Nursing, 2023, 4(6): 515-518.] DOI: 10.3761/j.issn.2096-7446.2023.06. 006.

46.Attia Hussein Mahmoud H, Parekh R, Dhandibhotla S, et al. Insight into neonatal sepsis: an overview[J]. Cureus, 2023, 15(9): e45530. DOI: 10.7759/cureus.45530.

47.Smith CL, Dickinson P, Forster T, et al. Identification of a human neonatal immune-metabolic network associated with bacterial infection[J]. Nat Commun, 2014, 5: 4649. DOI: 10.1038/ncomms5649.